Genea Biomedx

What Genea Biomedx does

Genea Biomedx is a Sydney-based medical device company that designs, manufactures and distributes IVF and assisted reproductive technology (ART) equipment globally, operating as part of the Genea Group and serving IVF clinics, fertility centres and ART laboratories worldwide. The company's portfolio spans four solution areas: embryology (Geri® time-lapse incubator, Gems® culture media, Gavi® automated vitrification), electronic witnessing (Gidget®, Guardian), genetic testing (Genie Solution PGT platform), cryostorage (Gelida 47/800), and andrology instruments (Glimmer Flow Cytometer, Glimmer Semen Analyser). The technology is anchored by multiple 'world-first' products, including the first humidified time-lapse benchtop incubator (Geri®), the first automated vitrification instrument (Gavi®), and the third generation of the world's first sequential culture media (Gems®), with manufacturing conducted in ISO 13485:2016-accredited facilities in Sydney and quality certification covering MDSAP jurisdictions including Australia, Brazil, Canada, Japan and the United States (valid through May 2027).

Genea Biomedx's technology stack integrates proprietary hardware with an AI layer: Geri® captures high-resolution embryo images every five minutes across six independent chambers, and Geri® Connect & Assess provides LAN-based remote monitoring with three embryo assessment modules (Geri Assess 1.0 manual morphology, Geri Assess 2.0 AI-based kinetics, and the Eeva™ System) plus third-party AI tool compatibility. The upcoming AI Toolbox (April 2026) extends this into an enablement platform allowing IVF labs to custom-train their own embryo assessment models on proprietary clinical data while preserving data sovereignty. The Genie Secure Data Analysis System processes all PGT genetic data 100% on-premise via a local LAN-connected server, addressing strict data protection requirements.

Genea Biomedx generates revenue through a hybrid model combining direct capital equipment sales (Geri®, Gavi®, Gelida systems, Genie Sequencer), recurring consumables and media (Geri dishes, Gavi Pods/cartridges, Gems® media suite, Genie kits), and professional services through a distributor training academy. Distribution is global via a direct sales force complemented by an authorized distributor network with territory-exclusive partnerships (e.g., the September 2024 exclusive Australian partnership with Genea Fertility), and the company maintains wholly-owned subsidiaries in the UK, Spain and France alongside its Sydney headquarters.

Name

Genea Biomedx

Legal name

Genea Biomedx Pty Ltd

Website

https://geneabiomedx.com

Company type

Private

Founded year

1991

Operating status

Operating

Headcount range

101–250 employees

Short description

Genea Biomedx designs and manufactures proprietary IVF medical devices and consumables—including time-lapse incubators, automated vitrification systems, culture media, electronic witnessing tools, and PGT genetic testing platforms—serving IVF clinics and ART laboratories globally.

Ownership category

akta.pro rank

Product category

Assisted Reproductive Technology (IVF/ART) Medical Devices

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Biological Product (except Diagnostic) Manufacturing (325414)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ)

akta.pro secondary industry

Cryopreservation & Germplasm Banking (Semen/Embryos/Oocytes) (AFAEAJAH)

Keywords

• IVF medical devices
• Embryo culture media
• Fertility lab automation
• Preimplantation genetic testing
• Cryostorage systems

Headquarters

HQ city

Sydney

HQ country

Australia

HQ region

Oceania

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Instrument Sales (Capital Equipment): One-time capital equipment sales of Geri®, Gavi®, Gelida 47/800, Genie Sequencer, Glimmer Flow, and Glimmer Semen Analyser to IVF clinics and laboratories. Quotes are handled directly via sales representatives or authorised distributors.
2. Consumables and Media Sales: Recurring revenue from consumables used with Geri® (Geri dish, water bottles) and Gavi® (Medium Cartridge, Cassette, Tip & Seal Cartridge, Pod, LN2 Bucket), plus the Gems® media suite (gamete handling, growth, vitrification/warming media) typically sold per-batch to clinics with regular replenishment.
3. Genie PGT Genetic Analysis Solutions: Sale of Genie-A (Fast and Advanced) and Genie-Plus kits for preimplantation genetic testing, sequenced on the Genie Sequencer with data analysed on the Genie Secure Data Analysis Software — including kit consumables, sequencer hardware, and software.
4. Distributor Channel Margins: Margin generated through a global network of authorised distributors who resell Genea Biomedx instruments and consumables, supported by a formal distributor training program and territory-specific exclusivity (e.g., exclusive partnership in Australia with Genea Fertility).
5. Training, Support and Academy Services: Revenue from in-person or virtual technical training, distributor training via the Genea Biomedx Academy, technical support contracts, and access to on-site engineer services — supporting ongoing customer relationships post-sale.

Pricing tiers

Go-to-market motion4 records

Distribution channels4 records

Marketing channels8 records

Core offering

Genea Biomedx designs and manufactures an integrated portfolio of IVF and assisted reproductive technology (ART) hardware, consumables and software for fertility clinics and laboratories. The offering spans time-lapse incubators (Geri®), embryo culture media (Gems®), automated vitrification instruments (Gavi®), electronic witnessing and workflow systems (Gidget®, Guardian), an end-to-end preimplantation genetic testing platform (Genie Solution, Genie Sequencer, Genie Secure Data Analysis), and intelligent LN2 cryostorage (Gelida 47, Gelida 800), supported by an AI Toolbox that lets clinics custom-train embryo assessment models. Revenue is generated through one-time capital equipment sales paired with recurring consumable and media replenishment, distributed globally via direct sales and an authorised distributor network.

Product overview

Genea Biomedx delivers a holistic, platform-plus-modules portfolio of IVF and embryology technologies built on more than 30 years of clinical heritage from Sydney IVF, organised into four solution areas: Embryology Solution (Geri® time-lapse incubator with the Geri® Connect & Assess remote monitoring software suite, Gems® third-generation culture media suite including Geri Medium, Gavi® automated vitrification instrument, and the Guardian and Gidget® electronic witnessing systems), Genetic Solution (the Genie Solution end-to-end PGT platform comprising Genie-A Solution, Genie-Plus Solution, Genie Sequencer, and Genie Secure Data Analysis System), Cryostorage Solution (Gelida 47 and Gelida 800 intelligent liquid nitrogen storage systems managed via Gelida Connect), and Andrology Laboratory instruments (Glimmer Flow Cytometer and Glimmer Semen Analyser). The portfolio is underpinned by the AI Toolbox enablement platform, which lets IVF labs custom-train embryo assessment models on proprietary data, with Geri® Connect & Assess integrating three embryo assessment modules (Geri Assess 1.0, Geri Assess 2.0, and Eeva™) plus third-party AI tools, and the Gidget® system using an Apple iPod Touch-based handheld scanner. All products are manufactured under ISO 13485:2016 quality management, with Gelida 47 additionally CE Class 1 marked and the company holding MDSAP certification.

Differentiator

Problem solved

Functional benefit

Brands

• Geri®: Award-winning benchtop time-lapse incubator with continuous embryo monitoring; the world's first humidified time-lapse incubator with six individual patient chambers.
• Gems®
• Gavi®
• Gidget®
• Guardian
• Genie Solution
• Gelida
• Geri® Connect & Assess

Products and services

• Geri® Humidified Time-Lapse Incubator Compact modular benchtop incubator providing undisturbed embryo culture with continuous time-lapse monitoring and individualised patient chambers for IVF clinics and embryology laboratories.
• Geri® Connect & Assess Software platform that links multiple Geri® incubators over a LAN to provide centralised embryo assessment, real-time monitoring, AI-assisted selection and patient-facing review for IVF clinics.
• Gems® Third-Generation Culture Media Suite Complete sequential and continuous embryo culture media suite covering gamete handling, growth media and vitrification/warming solutions, manufactured in ISO 13485-accredited Sydney facilities for IVF clinics.
• Gavi® Automated Vitrification Instrument Automated vitrification instrument with Gavi® Pod closed-system consumable that standardises equilibration and warming for oocytes and embryos in IVF labs and fertility preservation programmes.
• Guardian Dual-Technology Electronic Witnessing System Electronic witnessing system for IVF labs that supports both RFID and QR identification technologies for sample traceability and ID-check verification, with handheld PDA, RFID desktop reader and dashboard.
• Gidget® Electronic Witnessing and Workflow Management System Electronic witnessing and ART workflow management system with Apple iPod Touch-based handheld scanners, real-time dashboard, configurable workflows and audit-grade traceability reports for IVF laboratories.
• Genie Solution (End-to-End PGT Platform) End-to-end preimplantation genetic testing (PGT) platform combining Genie Kits for library preparation, the Genie Sequencer for sequencing, and on-premise Genie Data Analysis Software for PGT-A, PGT-SR and PGT-M reporting.
• Genie-A Solution (PGT-A Kit) Preimplantation genetic testing kit for detecting CNV, ploidy, Sibling QC and ROH in embryo biopsy samples, available in Fast and Advanced workflow options for IVF clinics.
• Genie-Plus Solution (Comprehensive PGT Kit) Comprehensive PGT kit combining monogenic disorder detection, structural rearrangement analysis and aneuploidy screening in a single preimplantation embryo biopsy workflow.
• Genie Sequencer (Benchtop Sequencer) Compact benchtop sequencer for sequencing sample libraries prepared through the Genie Kits, supporting carrier screening, whole exome sequencing and whole genome sequencing in IVF labs.
• Genie Secure Data Analysis System On-premise secure data analysis server that processes Genie Sequencer genetic data locally on Genie Data Analysis Software, eliminating cloud processing for IVF clinics in data-protection-sensitive markets.
• Gelida 47 Intelligent LN2 Storage System Intelligent liquid nitrogen storage tank with real-time temperature and LN2 monitoring, authenticated access, app-based remote management and integration with Gelida Connect for fleet oversight. CE Class 1 marked.
• Gelida 800 Advanced Cryostorage System High-capacity intelligent cryostorage system with 30,000+ sample capacity, real-time monitoring, automated LN2 replenishment, app-based remote management, dual verification and UPS backup for biobanks and ART labs.

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability14 records

Feature9 records

Partnerships

Three partnerships are on record, tiered flagship (exclusive territory), major and flagship (parent).

• Genea Fertilityflagship (exclusive territory)Channel Partner/ Reseller/ Distributor · 12 September 2024Genea Biomedx solidified an exclusive partnership with Genea Fertility covering Australia in September 2024. As a fellow Genea Group entity, Genea Fertility serves as the exclusive Australian channel for Genea Biomedx's IVF instruments, consumables, and services in this territory.
• Merck KGaAmajorStrategic or Co-development Partner · 1 June 2020Merck KGaA entered into a partnership with Genea Biomedx in June 2020 to advance fertility technologies, as cited in third-party market reporting on the assisted reproductive technology market.
• Genea Group (parent/sister entities including Genea Biomedx Pty Ltd, Genea Biomedx UK Ltd, Biomedx Innovations Pty Ltd, Biomedx Innovations SL, Biomedx Innovations SAS)flagship (parent)OthersGenea Biomedx is part of the Genea Group of companies under the Biomedx banner. Sister subsidiaries in Australia, the UK, Spain, and France share data privacy, compliance and commercial practices as part of a unified group.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Vitrolife: Sweden-based global IVF company whose product portfolio directly overlaps Genea Biomedx's embryology and genetics offerings — including culture media, time-lapse incubators, and PGT/consumables — making it the closest like-for-like competitor in human ART devices and media.
• CooperSurgical: Major ART and reproductive medicine business (including the Wallace, Origio and RI brands) selling IVF devices, micromanipulation, media and consumables to fertility clinics worldwide; competes head-to-head with Genea Biomedx's Geri, Gems, Gavi and electronic witnessing lines.
• Esco Medical: ART equipment manufacturer of benchtop time-lapse incubators (MIRI® family) and IVF lab devices; closely comparable to Genea Biomedx's Geri® incubator and connected monitoring platform within the embryology incubator category.
• FUJIFILM Irvine Scientific: Supplier of IVF culture media, cryopreservation solutions and ART consumables used by the same embryology labs Genea Biomedx serves; directly competes with Gems® media and Gavi® vitrification reagents.
• Hamilton Thorne: Provider of precision instruments and consumables for the IVF/ART market including laser systems for embryo biopsy and sperm analysis; comparable to Genea Biomedx across IVF lab equipment, andrology (Glimmer) and embryo manipulation workflows.
• Kitazato Corporation: Japanese ART consumables and vitrification company whose Cryotop® system is a global standard in oocyte/embryo vitrification, directly competing with Genea Biomedx's Gavi® automated vitrification instrument and consumables.

Emerging players

• Rocket Medical: UK-based medical device company with an ART and andrology product range (including ICSI, catheter and lab consumables) that serves the same fertility clinic customers with overlapping, though less software- and AI-driven, offerings.

Others

• Cryoport Systems: Specialist in temperature-controlled cryogenic logistics and biostorage infrastructure serving the reproductive medicine and cell-and-gene therapy markets; an adjacent enabler of the IVF cryostorage workflow that Genea Biomedx's Gelida systems plug into.
• Eppendorf: Global lab equipment supplier (pipettes, bioreactors, cell handling consumables) commonly used alongside IVF lab instrumentation; serves the same embryology labs but in adjacent — not competing — product categories.

Broad incumbents

• Merck KGaA (Life Science / Sigma-Aldrich ART portfolio): Global life-science major with an ART and embryology portfolio (media, cryopreservation, lab tools) that overlaps Genea Biomedx's media and consumables lines; also a 2020 strategic partner, making it both competitor and collaborator in the fertility technology stack.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/GeneaBiomedx
• Facebookfacebook.com/GeneaBiomedx
• LinkedInlinkedin.com/company/geneabiomedx

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Genea Biomedx